These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 22387888

  • 21. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
    van der Kolk DM, de Vries EG, van Putten WJ, Verdonck LF, Ossenkoppele GJ, Verhoef GE, Vellenga E.
    Clin Cancer Res; 2000 Aug; 6(8):3205-14. PubMed ID: 10955805
    [Abstract] [Full Text] [Related]

  • 22. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
    Dahan A, Amidon GL.
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
    [Abstract] [Full Text] [Related]

  • 23. Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.
    Baltes S, Gastens AM, Fedrowitz M, Potschka H, Kaever V, Löscher W.
    Neuropharmacology; 2007 Feb; 52(2):333-46. PubMed ID: 17045309
    [Abstract] [Full Text] [Related]

  • 24. Glucagon-like peptide 2 prevents down-regulation of intestinal multidrug resistance-associated protein 2 and P-glycoprotein in endotoxemic rats.
    Arana MR, Tocchetti GN, Zecchinati F, Londero AS, Dominguez C, Perdomo V, Rigalli JP, Villanueva SSM, Mottino AD.
    Toxicology; 2017 Sep 01; 390():22-31. PubMed ID: 28842383
    [Abstract] [Full Text] [Related]

  • 25. Inflammation and interleukin-6 mediate reductions in the hepatic expression and transcription of the mdr1a and mdr1b Genes.
    Sukhai M, Yong A, Kalitsky J, Piquette-Miller M.
    Mol Cell Biol Res Commun; 2000 Oct 01; 4(4):248-56. PubMed ID: 11409920
    [Abstract] [Full Text] [Related]

  • 26. Expression and function of efflux drug transporters in the intestine.
    Takano M, Yumoto R, Murakami T.
    Pharmacol Ther; 2006 Jan 01; 109(1-2):137-61. PubMed ID: 16209890
    [Abstract] [Full Text] [Related]

  • 27. A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinib.
    Graber-Maier A, Gutmann H, Drewe J.
    Mol Pharm; 2010 Oct 04; 7(5):1618-28. PubMed ID: 20701289
    [Abstract] [Full Text] [Related]

  • 28. Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1.
    Takeuchi T, Yoshitomi S, Higuchi T, Ikemoto K, Niwa S, Ebihara T, Katoh M, Yokoi T, Asahi S.
    Pharm Res; 2006 Jul 04; 23(7):1460-72. PubMed ID: 16779700
    [Abstract] [Full Text] [Related]

  • 29. ATP binding cassette transporters in two distinct compartments of the skin contribute to transdermal absorption of a typical substrate.
    Hashimoto N, Nakamichi N, Uwafuji S, Yoshida K, Sugiura T, Tsuji A, Kato Y.
    J Control Release; 2013 Jan 10; 165(1):54-61. PubMed ID: 23089896
    [Abstract] [Full Text] [Related]

  • 30. Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1/P-gp, MRP2, and BCRP.
    Kowalski P, Surowiak P, Lage H.
    Mol Ther; 2005 Apr 10; 11(4):508-22. PubMed ID: 15771954
    [Abstract] [Full Text] [Related]

  • 31. Influence of chemosensitizers on resistance mechanisms in daunorubicin-resistant Ehrlich ascites tumour cells.
    Nielsen D, Eriksen J, Maare C, Friche E, Skovsgaard T.
    Cancer Chemother Pharmacol; 2002 Jun 10; 49(6):453-60. PubMed ID: 12107549
    [Abstract] [Full Text] [Related]

  • 32. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A, Maeda K, Kamiyama E, Sugiyama D, Kondo T, Shiroyanagi Y, Nakazawa H, Okano T, Adachi M, Schuetz JD, Adachi Y, Hu Z, Kusuhara H, Sugiyama Y.
    Drug Metab Dispos; 2007 Dec 10; 35(12):2166-76. PubMed ID: 17823233
    [Abstract] [Full Text] [Related]

  • 33. Regulation of hepatic drug transporter activity and expression by organochlorine pesticides.
    Bucher S, Le Vee M, Jouan E, Fardel O.
    J Biochem Mol Toxicol; 2014 Mar 10; 28(3):119-28. PubMed ID: 24464585
    [Abstract] [Full Text] [Related]

  • 34. Regulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobiotic-induced cytotoxicity.
    Arias A, Rigalli JP, Villanueva SS, Ruiz ML, Luquita MG, Perdomo VG, Vore M, Catania VA, Mottino AD.
    Toxicology; 2014 Jun 05; 320():46-55. PubMed ID: 24685904
    [Abstract] [Full Text] [Related]

  • 35. MDR1 causes resistance to the antitumour drug miltefosine.
    Rybczynska M, Liu R, Lu P, Sharom FJ, Steinfels E, Pietro AD, Spitaler M, Grunicke H, Hofmann J.
    Br J Cancer; 2001 May 18; 84(10):1405-11. PubMed ID: 11355955
    [Abstract] [Full Text] [Related]

  • 36. Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: comparison between human segments and Caco-2 cells.
    Seithel A, Karlsson J, Hilgendorf C, Björquist A, Ungell AL.
    Eur J Pharm Sci; 2006 Jul 18; 28(4):291-9. PubMed ID: 16704924
    [Abstract] [Full Text] [Related]

  • 37. Expression of efflux transporters in human ocular tissues.
    Chen P, Chen H, Zang X, Chen M, Jiang H, Han S, Wu X.
    Drug Metab Dispos; 2013 Nov 18; 41(11):1934-48. PubMed ID: 23979916
    [Abstract] [Full Text] [Related]

  • 38. Rapid induction of long-lasting drug efflux activity in brain vascular endothelial cells but not malignant glioma following irradiation.
    Andersson U, Grankvist K, Bergenheim AT, Behnam-Motlagh P, Hedman H, Henriksson R.
    Med Oncol; 2002 Nov 18; 19(1):1-9. PubMed ID: 12025885
    [Abstract] [Full Text] [Related]

  • 39. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium.
    Swed A, Eyal S, Madar I, Zohar-Kontante H, Weiss L, Hoffman A.
    Mol Pharm; 2009 Nov 18; 6(6):1883-90. PubMed ID: 19722701
    [Abstract] [Full Text] [Related]

  • 40. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
    Reese MJ, Savina PM, Generaux GT, Tracey H, Humphreys JE, Kanaoka E, Webster LO, Harmon KA, Clarke JD, Polli JW.
    Drug Metab Dispos; 2013 Feb 18; 41(2):353-61. PubMed ID: 23132334
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.